MED-EL · Cochlear/Auditory Implant · Marketed
MarketedDeviceAuditory BCI / NeurotechStronger sources
Explore
Program Map
Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.
161Main(26 active)
148Status checked
135Strong
320Backlog
More filters and sort (2 active)
6 records in Main database · 5 strong · 5 status checked
Cilcare SAS · Small Molecule · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy
Population
AdultDiabetesCochlear SynaptopathyHidden Hearing Loss
Eli Lilly and Company · Gene Therapy · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
90%
Indications
Vestibular SchwannomaHearing Loss
Population
AdultUnilateralVestibular SchwannomaHearing Adjacent
Ava · AI Audio/Speech Accessibility Software · Marketed
MarketedSoftware/NeurotechAI AudioStronger sources
Evidence
company
Confidence
90%
Indications
Hearing Loss
Population
AdultPediatricDeaf / Hard of HearingCaptioning
Microsoft · AI Audio/Captioning · Marketed
MarketedSoftware/NeurotechAI AudioStronger sources
Evidence
company
Confidence
88%
Indications
Hearing LossCommunication Impairment
Population
AdultDeaf / Hard of HearingCaptioningSpeech To Text
Lunan Better Pharmaceutical Co., Ltd. · Small Molecule · Phase 2/3
ActiveTherapeutic
Evidence
trial
Confidence
88%
Indications
Hearing LossTinnitus
Population
AdultUnilateralMeniere Disease